CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer
Tumor mutational burden (TMB) is one of the most significant predictive biomarkers of immunotherapy efficacy in non-small cell lung cancer (NSCLC). Radiomics allows high-throughput extraction and analysis of ...